What is the stock code for Sun Pharma?
About Sun Pharmaceutical Industries Ltd. Sun Pharma is in the Pharmaceuticals sector. It is listed on the BSE with a BSE Code of 524715 and the NSE with an NSE Code of SUNPHARMA.
What is the market cap of Sun Pharmaceutical Industries Ltd?
Amount Invested (in Cr.) Amount Invested (in Cr.) Amount Invested (in Cr.) Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 206,282.82 Crore) operating in Pharmaceuticals sector.
Is Sun Pharmaceutical Industries’ dividend yield good?
For the year ending June 2019 Sun Pharmaceutical Industries has declared an equity dividend of 275.00% amounting to Rs 2.75 per share. At the current share price of Rs 417.50 this results in a dividend yield of 0.66%. The company has a good dividend track report and has consistently declared dividends for the last 5 years.
How many promoters pledged Sun Pharmaceuticals shares in last quarter?
Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 6.52% of promoter holdings Net Profit (Rs.) Net Sales (Rs.) Sun Pharmaceutical Inds. Ltd is an international speciality pharma company.The company also makes active pharmaceutical ingredients.
See more
Will Sun Pharma shares increase?
Sun Pharmaceuticals (SUNPHARMA) buy sell technical analysis & forecast predictions with share price targets for today short term. Important intraday levels for the stock on upside are: 873 and 892 and 910 If the stock moves up, then it will find resistance near these levels....Downside target870.5Upside target881.6810 more rows
Has Sun Pharma declared dividend?
Sun Pharmaceutical Industries Ltd. For the year ending March 2022 Sun Pharmaceutical Industries has declared an equity dividend of 1000.00% amounting to Rs 10 per share. At the current share price of Rs 868.35 this results in a dividend yield of 1.15%.
Which company gives best dividend in India?
Top 10 Dividend Paying Stocks in India in the Last 3 YearsNameMarket Cap (Rs, Cr)Dividend Yield (%)Vedanta Ltd85,46319.51Indian Oil Corporation Ltd97,01311.92Power Grid Corporation of India1,45,26411.88Coal India Ltd1,08,9889.616 more rows•Jun 21, 2022
Is IOC giving dividend in 2022?
Indian Oil Corporation Ltd. For the year ending March 2022 Indian Oil Corporation has declared an equity dividend of 114.00% amounting to Rs 11.4 per share. At the current share price of Rs 72.15 this results in a dividend yield of 15.8%.
Lupin: A long gestation period ahead
Emkay Global Financial Services
Trade Spotlight | What should you do with Navin Fluorine, Tata Steel, Hatsun Agro and Sun Pharma? Feb 02 2022 07:02 AM
Sun Pharmaceutical Industries - Disclosures under Reg. 31 (1) and 31 (2) of SEBI (SAST) Regulations, 2011
Company analysis giving insights of fundamentals, earnings, relative valuations, risk, price momentum and inside trading.
Sun Pharmaceutical Industries Limited
The Exchange has received Disclosure under Regulation 31 (1) and 31 (2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2....
What is Sun Pharmaceutical?
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 27, 2022, titled "Sun Pharma launche....
Where is Sun Pharmaceutical Industries located?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients primarily in India ...
What is Sun Pharma?
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients primarily in India and the United States. It is largest Pharma Company in India. The company offers formulations in various ...
What is the most sought after drug in India?
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) (Bloomberg: SUNP.IN) (NSE: SUNPHARMA) (BSE: 524715), "Sun Pharma" and includes its subsidiaries and/or associate companies) and Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing essential dermatological conditions, today announced the expiration of the applicable waiting period under the US Hart-Scott-Rodin
Who makes favipiravir?
Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in India, which saw a surge of 50,000-plus infections for the sixth straight day on Tuesday.
What is the most sought after drug in India?
India's Sun Pharmaceutical Industries Ltd said on Tuesday it would soon begin selling its version of favipiravir, becoming the latest generic drugmaker to supply the antiviral to treat COVID-19 in the world's third worst-hit nation.
Who makes favipiravir?
Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in India, which saw a surge of 50,000-plus infections for the sixth straight day on Tuesday.
Who is Merck partnering with?
India's Sun Pharmaceutical Industries Ltd said on Tuesday it would soon begin selling its version of favipiravir, becoming the latest generic drugmaker to supply the antiviral to treat COVID-19 in the world's third worst-hit nation.
